Search research articles
Contact Us
Filters
Showing results (91-100 of 190) with videos related to
Page
of 19
Sort By:
The Oncologist
|
July 9, 2011
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice
Charles D Blanke, Richard M Goldberg, Axel Grothey, et al.
Journal of the National Cancer Institute
|
December 14, 2018
Current Activities of the Coalition of Cancer Cooperative Groups
Monica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
British Journal of Cancer
|
September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)
S G Louie, B Ely, H-J Lenz, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2011
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal, Cathryn Rankin, Heinz-Josef Lenz, et al.
British Journal of Cancer
|
January 16, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
A B El-Khoueiry, C Rankin, A B Siegel, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2024
Pragmaticism in Cancer Clinical Trials
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, et al.
Investigational New Drugs
|
July 13, 2011
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B El-Khoueiry, Cathryn J Rankin, Edgar Ben-Josef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials
Charles D Blanke, Brian M Bot, David M Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer
C D Blanke, J Shultz, J Cox, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial
Stephen K Williamson, Sheryl A McCoy, David R Gandara, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 190) with videos related to
Sort By:
Page
of 19
The Oncologist
|
July 9, 2011
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice
Charles D Blanke, Richard M Goldberg, Axel Grothey, et al.
Journal of the National Cancer Institute
|
December 14, 2018
Current Activities of the Coalition of Cancer Cooperative Groups
Monica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
British Journal of Cancer
|
September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)
S G Louie, B Ely, H-J Lenz, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2011
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal, Cathryn Rankin, Heinz-Josef Lenz, et al.
British Journal of Cancer
|
January 16, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
A B El-Khoueiry, C Rankin, A B Siegel, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2024
Pragmaticism in Cancer Clinical Trials
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, et al.
Investigational New Drugs
|
July 13, 2011
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B El-Khoueiry, Cathryn J Rankin, Edgar Ben-Josef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials
Charles D Blanke, Brian M Bot, David M Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer
C D Blanke, J Shultz, J Cox, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial
Stephen K Williamson, Sheryl A McCoy, David R Gandara, et al.
Page
of 19